@FierceMedDev: The Senate passed the FDA user fee bill 96-1, a move praised by members of the device industry. Story | Follow @FierceMedDev
@MarkHFierce: Folks, there's still time to submit your nominations for the FierceMedicalDevices Fierce 15 private device developers. Survey | Follow @MarkHFierce
> The deal is done. Orthofix International ($OFIX) has completed the $157.5 million sale of its Breg sports medicine unit to Water Street Healthcare Partners. Release
> Fenwal obtained Canadian regulatory approval for its Aurora plasmapheresis system, a device designed to collect plasma from blood donors. Release
> Vibrynt, a startup making a new obesity treatment device, has raised half of a $5.5 million offering, MedCity News reports. Story
> The Minnesota company Uroplasty ($UPI) will begin testing its neuromodulation treatment for overactive bladders as a treatment for fecal incontinence in a trial set to begin this summer, MedCity News reports. Story
> Cepheid ($CPHD) gained FDA clearance to use its new GeneXpert Infinity-80 system to process its flu molecular diagnostic test. Release
> Sensor-augmented insulin pump therapy with a low-glucose suspend function looks to be safe for patients with Type 1 diabetes, according to a new study. Blog
> Israeli device company Medigus gained FDA clearance for its SRS Endoscopic system, which is designed to treat gastroesophageal reflux disease. Story
Biotech News
@FierceBiotech: FDA panel mixed on Pfizer's rare disease drug. More | Follow @FierceBiotech
@RyanMFierce: Bloomberg: After dubious Sirtris deal, Glaxo has targeted partners in recent M&As. Report | Follow @RyanMFierce
@JohnCFierce: EMA recommends Vertex's Kalydeco for cystic fibrosis population. Item | Follow @JohnCFierce
> Elan boss: Climate improved for Alzheimer's drugs. Article
> Sangart stashes $50M funding for oxygenation drugs. News
> GSK gambles on biotech partners after dubious M&A deal. More
Pharma News
@FiercePharma: Watson asks for FDA approval on generic Testim, Auxilium's testosterone drug. Auxilium sues (of course). Story | Follow @FiercePharma
> House could vote on FDA bill next week. Report
> EMA continues Pradaxa support but wants clearer warnings. Article
> Takeda takes buying binge into Brazil with $265M Multilab deal. Item
> Ranbaxy brings in U.S. consultants as part of consent decree. News
And Finally... ConforMIS says its iTotal CR knee replacement system won the silver medal in the "Implant and Tissue-Replacement Products" category for the 2012 Medical Design Excellence Awards. Release